Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical organizations, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use – and failure to do so may possibly be grounds for compensation. Our lawyers are operating difficult to get those hurt by the drug the compensation they may be entitled to.
Even though bleeding is a typical complication associated with anticoagulants, it has been alleged that Xarelto is far more unsafe than traditional blood thinners since no antidote exists to reverse its blood-thinning effects. This indicates that, inside click the following page event of an emergency, patients may possibly be at threat for irreversible bleeding problems, like life-threatening internal and gastrointestinal hemorrhaging.
Should you or perhaps a loved a single suffered a serious bleeding event right after taking Xarelto, you might have legal recourse. For much more data, contact us today to possess your case reviewed, free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral costs. Furthermore, they may be in search of punitive damages, that are generally awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Getting Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.
Visit this page for far more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.